Completed NA INTERVENTIONAL 3-arm NCT03984916

Study of the Bioavailability of Three Hesperidin Extracts. (HESPERIDIN)

Interventional Study for the Comparison of the Bioavailability of Three Hesperidin Extracts (HESPERIDIN).

Sponsor: Fundació Eurecat

Interventions Cardiose Hesperidin Pharma Hesperidin Pharma_M

Updated 6 times since 2019 Last updated: Feb 25, 2022 Started: Jun 13, 2019 Primary completion: Mar 2, 2020 Completion: Mar 2, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Biological Availability, this trial is completed. The trial is conducted by Fundació Eurecat and has accumulated 6 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Mar 2022 — Jul 2024 [monthly]

Completed NA

Status: Unknown Status → Completed
Oct 2021 — Mar 2022 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Not Yet Recruiting NA

▶ Show 1 earlier version

Jul 2019 — Jan 2021 [monthly]

Not Yet Recruiting NA

First recorded

Jun 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundació Eurecat
Hospital Universitari Sant Joan de Reus
Technological Centre of Nutrition and Health, Spain
University Rovira i Virgili

Data source: Technological Centre of Nutrition and Health, Spain

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Reus, Spain